Ana Cespedes
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Ana Cespedes is the founder of Spanish Women Leaders Life Science.
Current jobs include Chief Executive Officer & Director at Vitamin Angel Alliance, Inc. since 2025, Independent Non-Executive Director at argenx SE since 2022, Director at the University of Navarra, Member at London School of Economics & Political Science, Member-Oncology Data at National Institutes of Health, Member at Living Mindfulness SL, and Member at Congreso de los Diputados.
Former jobs include Managing Director at Merck Healthcare Foundation, Managing Director at Serono Iberia, Head-Corporate Affairs at Merck SL, Senior Vice President-Global Marketing & Strategy at Merck KGAA Unsponsored ADR Facility, and Chief Operating Officer at International AIDS Vaccine Initiative, Inc. Education includes an MBA from the University of Navarra and undergraduate and doctorate degrees from Universidad Complutense de Madrid.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.02.2026 | 1’294 ( 0% ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARGENX SE | Direktor/Vorstandsmitglied | 12.12.2022 |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Congreso de los Diputados
Congreso de los Diputados General GovernmentGovernment Lower house of legislative assembly | Corporate Officer/Principal | - |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
University of Navarra
University of Navarra Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Vitamin Angel Alliance, Inc.
Vitamin Angel Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Provides nutrition development and vitamin supplementation programs | Vorstandsvorsitzender | 01.03.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Merck KGAA Unsponsored ADR Facility | Vertrieb & Marketing | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Merck KGAA Unsponsored ADR Facility | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Complutense de Madrid
Universidad Complutense de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Navarra
University of Navarra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitamin Angel Alliance, Inc.
Vitamin Angel Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Provides nutrition development and vitamin supplementation programs | Commercial Services |
argenx SE
argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Congreso de los Diputados
Congreso de los Diputados General GovernmentGovernment Lower house of legislative assembly | Government |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen